Archives
Genetic Testing In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
About This Event
Genetic Testing In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Polycystic Kidney Disease (PKD) is the most common hereditary disease that can lead to kidney failure. Genetic testing is becoming more affordable and its use in the detection of autosomal dominant polycystic kidney disease (ADPKD) mutations for diagnostic and research purposes is more widespread. In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed. The information provided in a typical clinical genetic report and interpretation of the same will also be presented.
Bulla Gastrobar
Charlotte, North Carolina 28211 United States + Google Map
Joshua Lipschutz, MD
Medical University, South Carolina*
Dr Lipschutz completed his undergraduate studies, medical school, and residency at Indiana University. He then went on to complete his Nephrology Fellowship at the University of California, San Francisco (UCSF). After his medical training, Dr Lipschutz successfully established an internationally recognized independent research program that better explained the etiology of polycystic kidney disease at the University of Pennsylvania. This work and much more has been published in over 80 scientific manuscripts and has been supported by multiple grants from the National Institutes of Health, Veterans Affairs, and private foundations.
In 2014, Dr Lipschutz took a Professor of Medicine position at the Medical University of South Carolina where he also serves as the Director of the Renal Division and the Arthur Williams Chair in Nephrology. Finally, Dr Lipschutz selflessly serves his country and is a Colonel in the South Carolina Army National Guard.
Michael Filsinger, PA-C, MPA
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.
*Dr Joshua Lipschutz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Michael Filsinger is an employee of OPDC.
